Screening in Emergency Department Could ID Previously Unrecognized Diabetes
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 10, 2023 -- Screening for type 2 diabetes (T2D) or prediabetes in emergency departments could identify previously undiagnosed cases, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held from Oct. 2 to 6 in Hamburg, Germany.
Edward Jude, M.D., from the Tameside and Glossop Integrated Care National Health Service Foundation Trust in Ashton-under-Lyne, England, and colleagues screened 1,388 individuals attending an emergency department and not known to have diabetes, using hemoglobin A1c (HbA1c). The Finnish Diabetes Risk Score (FINDRISC), which identifies individuals at high risk for developing T2D, was calculated for all patients.
The researchers found that 61.1 percent of the patients had normal glucose tolerance, while 30.2 and 8.6 percent had prediabetes and diabetes, respectively, with similar proportions seen in men and women. Each unit increase in the FINDRISC was associated with a significant increase in the risk for prediabetes and diabetes (odds ratios, 1.09 and 1.16, respectively); after adjustment for age and sex, the associations were attenuated but remained significant (odds ratios, 1.07 and 1.15, respectively). A higher incidence of glucose intolerance was seen for South Asian and other ethnic minorities compared with Caucasians (42.65 versus 37.8 percent), and they were twice as likely to have prediabetes or diabetes (odds ratios, 1.90 and 2.61, respectively).
"Opportunistic HbA1c-based screening in accident & emergency departments, particularly those in high-risk and hard to reach groups, could make an important contribution to identifying undiagnosed individuals who will benefit from early treatment and lifestyle changes and so reduce their risks of long-term complications," Jude said in a statement.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
ENDO: Cardiovascular Events Occur Less Often With GLP1-RA, SGLT-2i for T2D, Liver Disease
FRIDAY, June 7, 2024 -- For adults with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), glucagon-like peptide 1 receptor agonists...
Mortality in Rheumatic Heart Disease Is High
FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June...
Higher County-Level Prostate Cancer Screening Tied to Better Outcomes
FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.